LMD-A

CAS No. 850330-77-7

LMD-A( CCR8 antagonist LMD-A )

Catalog No. M16174 CAS No. 850330-77-7

LMD-A (CCR8 antagonist LMD-A) is a highly potent, small molecule antagonist of chemokine receptor CCR8 with EC50 of 2.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1773 Get Quote
50MG 3582 Get Quote
100MG 4950 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LMD-A
  • Note
    Research use only, not for human use.
  • Brief Description
    LMD-A (CCR8 antagonist LMD-A) is a highly potent, small molecule antagonist of chemokine receptor CCR8 with EC50 of 2.5 nM.
  • Description
    LMD-A (CCR8 antagonist LMD-A) is a highly potent, small molecule antagonist of chemokine receptor CCR8 with EC50 of 2.5 nM; inhibits 10 nM CCL1-induced activation of CCR8 with EC50 of 12 nM, inhibits 4DE4 cells cell migration induced by 3 nM CCL1 with EC50 of 0.58 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CCR8 antagonist LMD-A
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    850330-77-7
  • Formula Weight
    508.637
  • Molecular Formula
    C27H32N4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=C2C=CC=C(S(=O)(N[C@H]3[C@H](C)CN(C([C@H](C)N)=O)CC3)=O)C2=CC=C1)C4=CC=CC=C4C
  • Chemical Name
    N-(5-(N-((3R,4R)-1-(L-alanyl)-3-methylpiperidin-4-yl)sulfamoyl)naphthalen-1-yl)-2-methylbenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rummel PC, et al. Br J Pharmacol. 2012 Nov;167(6):1206-17. 2. Barington L, et al. J Biol Chem. 2016 Jul 29;291(31):16208-20.
molnova catalog
related products
  • Ladarixin sodium

    A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM.

  • AZ 13381758

    A potent, small molecule CXCR2 inhibitor with IC50 of 26 nM and 30 nM for mCXCR2 and hCXCR2, respectively.

  • GSK812397

    GSK812397 is a potent, selective, noncompetitive, orally available antagonist of CXCR4 receptor.